Encorafenib Plus Cetuximab Approved in Europe for BRAF V600E-Mutant mCRC
Publish date unknown
The European Commission has approved encorafenib (Braftovi) in combination with cetuximab (Erbitux) for the treatment of adult patients with BRAF ...
Concept cloud